Immunotherapy with mosquito (Culex quinquefasciatus) extract: a double-blind, placebo-controlled study.

@article{Srivastava2007ImmunotherapyWM,
  title={Immunotherapy with mosquito (Culex quinquefasciatus) extract: a double-blind, placebo-controlled study.},
  author={Deepsikha Srivastava and Bhanu P. Singh and V. Thangam Sudha and N Arora and Shailendra Nath Gaur},
  journal={Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology},
  year={2007},
  volume={99 3},
  pages={
          273-80
        }
}
BACKGROUND Mosquito allergy is well established, but mosquito immunotherapy requires validation using clinical and immunologic variables. OBJECTIVE To evaluate the tolerability and efficacy of specific immunotherapy with Culex quinquefasciatus (mosquito) extract. METHODS We performed a randomized, double-blind, placebo-controlled trial of immunotherapy for 1 year in 40 patients with asthma, rhinitis, or both. Patients were evaluated by means of intradermal testing, symptom and drug scores… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 14 CITATIONS

Mosquito allergy.

  • Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
  • 2013